Ask AI
ProCE Banner Activity

Maximizing Efficacy and Minimizing Toxicities With Antibody–Drug Conjugates in Breast Cancer

Slideset

These downloadable slides summarize ADCs used to manage breast cancer, including their mechanisms of action, clinical indications, toxicity profiles, and guideline-based recommendations.

Released: September 16, 2025

Share

Provided by

Provided by Partners for Advancing Clinical Education (Partners) in partnership with Clinical Care Options, LLC

ProCE Banner

Supporters

The APP’s Guide to Patient-Centered Management of CDK4/6 Inhibitor Therapy for HR+/HER2- Breast Cancer

Supported by an educational grant from Lilly.

Optimizing CLL/SLL Care: Expert Strategies for APPs to Integrate New Targeted Therapies and Practice-Changing Evidence

Supported by an educational grant from Lilly.

Maximizing Efficacy and Minimizing Toxicities With Antibody–Drug Conjugates in Breast Cancer

Supported by an educational grant from Gilead Sciences, Inc.

The APP’s Guide to Patient-Centered Management of BTK Inhibitor Therapy in Lymphoma

Supported by an educational grant from BeOne Medicines.

The How and Why of Bispecific Antibodies for R/R DLBCL: Best Practices for Exemplary Care

Supported by an educational grant from Genmab US, Inc.

BeOne Medicines

Genmab US, Inc.

Gilead Sciences, Inc.

Lilly

Partners

Clinical Care Options, LLC

ProCE Banner